Brief: Bone Therapeutics Says Cash Burn For FY 2019 Is Below Guidance
Jan 22 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* CASH BURN FOR FULL YEAR 2019 BELOW GUIDANCE
* NET CASH POSITION TOTALED EUR 8.6 MILLION (UNAUDITED
NUMBER) FOR
YEAR ENDED DECEMBER 31, 2019
* NET CASH UTILIZATION OF EUR 11.5 MILLION(UNAUDITED NUMBER)
FOR
FULL YEAR 2019 WAS BELOW COMPANY'S GUIDANCE OF EUR 12-13 MILLION
* COMPANY ANTICIPATES HAVING SUFFICIENT CASH TO CARRY OUT
ITS
BUSINESS OBJECTIVES INTO Q3 2020.
Source text for Eikon: ID:nGNEzD0y6
Further company coverage: BOTHE.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd